Investors

Partnering with Innovators to Advance Science

DRI Healthcare Trust is managed by DRI Capital Inc. (“DRI”), a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry, managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable, patent-protected cash flow streams derived from the sales of those important drugs, while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products, and proudly work with multiple repeat deal partners.

DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21, 2020, as amended.

DRI Healthcare Trust’s units are listed and trade on the Toronto Stock Exchange under “DHT.UN” in Canadian dollars and under “DHT.U” in U.S. dollars.

Investment Highlights

  • Partner of choice in the global pharmaceutical royalty sector focused on small to medium-sized growth transactions
  • Direct exposure to the fast-growing, global pharmaceutical industry
  • Attractive business model with less susceptibility to traditional pharmaceutical model risks
  • Growth strategy supported by DRI Capital’s proven origination capabilities
  • Robust cash flows from a high-quality, diversified pharmaceutical royalty portfolio

Stock Quote

TSX: DHT.UN (CAD)
TSX: DHT.U (USD)
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.